Vitrolife AB - Asset Resilience Ratio

Latest as of December 2025: 7.27%

Vitrolife AB (VITR) has an Asset Resilience Ratio of 7.27% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check VITR strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Skr809.00 Million

≈ $87.06 Million USD Cash + Short-term Investments

Total Assets

Skr11.12 Billion

≈ $1.20 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2025)

This chart shows how Vitrolife AB's Asset Resilience Ratio has changed over time. See Vitrolife AB net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Vitrolife AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Vitrolife AB stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr809.00 Million	7.27%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr809.00 Million	7.27%

Asset Resilience Insights

Limited Liquidity: Vitrolife AB maintains only 7.27% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Vitrolife AB Industry Peers by Asset Resilience Ratio

Compare Vitrolife AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Medacta Group SA SW:MOVE	Medical Devices	0.86%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	39.15%
Sinocare Inc SHE:300298	Medical Devices	3.53%
Xiangyu Medical Co. Ltd. A SHG:688626	Medical Devices	1.53%
INKON Life Technology Co Ltd SHE:300143	Medical Devices	5.73%
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%

Annual Asset Resilience Ratio for Vitrolife AB (2000–2025)

The table below shows the annual Asset Resilience Ratio data for Vitrolife AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	7.27%	Skr809.00 Million ≈ $87.06 Million	Skr11.12 Billion ≈ $1.20 Billion	+0.77pp
2024-12-31	6.51%	Skr1.14 Billion ≈ $122.14 Million	Skr17.45 Billion ≈ $1.88 Billion	+1.23pp
2023-12-31	5.27%	Skr861.00 Million ≈ $92.66 Million	Skr16.33 Billion ≈ $1.76 Billion	+2.46pp
2022-12-31	2.81%	Skr578.00 Million ≈ $62.20 Million	Skr20.55 Billion ≈ $2.21 Billion	-0.43pp
2021-12-31	3.24%	Skr630.09 Million ≈ $67.81 Million	Skr19.43 Billion ≈ $2.09 Billion	-38.99pp
2020-12-31	42.24%	Skr973.57 Million ≈ $104.77 Million	Skr2.31 Billion ≈ $248.06 Million	+42.24pp
2018-12-31	0.00%	Skr-1.00K ≈ $-107.62	Skr1.70 Billion ≈ $182.67 Million	-0.08pp
2015-12-31	0.08%	Skr842.00K ≈ $90.61K	Skr1.06 Billion ≈ $113.99 Million	+0.08pp
2014-12-31	0.00%	Skr17.00K ≈ $1.83K	Skr972.48 Million ≈ $104.65 Million	-0.02pp
2013-12-31	0.02%	Skr120.00K ≈ $12.91K	Skr487.81 Million ≈ $52.50 Million	-0.04pp
2012-12-31	0.06%	Skr289.00K ≈ $31.10K	Skr462.20 Million ≈ $49.74 Million	0.00pp
2011-12-31	0.06%	Skr295.00K ≈ $31.75K	Skr466.78 Million ≈ $50.23 Million	+0.04pp
2010-12-31	0.03%	Skr111.00K ≈ $11.95K	Skr429.39 Million ≈ $46.21 Million	-0.02pp
2009-12-31	0.04%	Skr147.00K ≈ $15.82K	Skr359.31 Million ≈ $38.67 Million	-0.01pp
2008-12-31	0.05%	Skr180.00K ≈ $19.37K	Skr342.66 Million ≈ $36.88 Million	-0.01pp
2007-12-31	0.06%	Skr183.00K ≈ $19.69K	Skr299.46 Million ≈ $32.23 Million	-10.68pp
2004-12-31	10.74%	Skr19.93 Million ≈ $2.15 Million	Skr185.54 Million ≈ $19.97 Million	-11.74pp
2001-12-31	22.49%	Skr73.77 Million ≈ $7.94 Million	Skr328.04 Million ≈ $35.30 Million	-5.98pp
2000-12-31	28.46%	Skr49.30 Million ≈ $5.31 Million	Skr173.22 Million ≈ $18.64 Million	--

pp = percentage points

About Vitrolife AB

ST:VITR Sweden Medical Devices

Market Cap

$1.33 Billion

Skr12.33 Billion SEK

Market Cap Rank

#7869 Global

#114 in Sweden

Share Price

Skr91.05

Change (1 day)

-1.67%

52-Week Range

Skr85.70 - Skr151.30

All Time High

Skr560.50